Childhood depression and other psychological factors significantly predict future initiation of tobacco and cannabis, researchers concluded.
Region: CA
While delta-8-THC and delta-9-THC were the most frequently identified synthetically derived cannabinoids, investigators also identified highly potent novel cannabinoids such as THCP and HHC in nearly one-third to one-half of products.
Respondents were most likely to report using cannabis to manage pain or mobility (81 percent), sleep (62 percent), PTSD or anxiety (43 percent), stress (43 percent), and depression (29 percent).
Marijuana retailers are associated with “significant reductions in mortality rates … for both accidental poisonings and opioid poisoning deaths.”
“This is the first study to date that provides the prevalence of CBD use in the general United States population,” investigators concluded.
California NORML, which pushed for the exemption, argued that cannabis smoke exposure does not pose similar risks to respiratory health as tobacco smoke.
“The odds of tobacco/nicotine use and co-use with cannabis were not associated with cannabis legalization,” the study’s authors concluded.
“Among participants with anxiety and/or depression and pre-existing sleep problems at baseline, using cannabis … was associated with fewer sleep problems at follow-up,” researchers reported.